279 related articles for article (PubMed ID: 24642580)
1. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial.
Zhou L; Zhang J; Chen M; Hou X; Li Z; Song Z; He L; Lin S
Am J Gastroenterol; 2014 Apr; 109(4):535-41. PubMed ID: 24642580
[TBL] [Abstract][Full Text] [Related]
2. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.
Paoluzi OA; Visconti E; Andrei F; Tosti C; Lionetti R; Grasso E; Ranaldi R; Stroppa I; Pallone F
J Clin Gastroenterol; 2010 Apr; 44(4):261-6. PubMed ID: 20195162
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
7. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
8. [Eradication Rates of 10-day Sequential Therapy for
Yoon K; Kim N
Korean J Gastroenterol; 2019 Feb; 73(2):99-104. PubMed ID: 30845386
[TBL] [Abstract][Full Text] [Related]
9. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
10. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
[TBL] [Abstract][Full Text] [Related]
11. Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Bontems P; Kalach N; Oderda G; Salame A; Muyshont L; Miendje DY; Raymond J; Cadranel S; Scaillon M
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):646-50. PubMed ID: 21701406
[TBL] [Abstract][Full Text] [Related]
12. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
13. Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
Arenz T; Antos D; Rüssmann H; Alberer M; Buderus S; Kappler M; Koletzko S
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):180-4. PubMed ID: 16877981
[TBL] [Abstract][Full Text] [Related]
14. Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laoudi F; Lisgos P; Spiliadi C; Papantoniou N; Karatapanis S
J Clin Gastroenterol; 2013 Mar; 47(3):228-32. PubMed ID: 22858517
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
Federico A; Nardone G; Gravina AG; Iovene MR; Miranda A; Compare D; Pilloni PA; Rocco A; Ricciardiello L; Marmo R; Loguercio C; Romano M
Gastroenterology; 2012 Jul; 143(1):55-61.e1; quize e13-4. PubMed ID: 22484118
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
McNicholl AG; Marin AC; Molina-Infante J; Castro M; Barrio J; Ducons J; Calvet X; de la Coba C; Montoro M; Bory F; Perez-Aisa A; Forné M; Gisbert JP;
Gut; 2014 Feb; 63(2):244-9. PubMed ID: 23665990
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Sardarian H; Fakheri H; Hosseini V; Taghvaei T; Maleki I; Mokhtare M
Helicobacter; 2013 Apr; 18(2):129-34. PubMed ID: 23121338
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.
Georgopoulos S; Papastergiou V; Xirouchakis E; Laudi F; Papantoniou N; Lisgos P; Spiliadi C; Fragou P; Skorda L; Karatapanis S
Helicobacter; 2012 Feb; 17(1):49-53. PubMed ID: 22221616
[TBL] [Abstract][Full Text] [Related]
19. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
20. Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.
Alsohaibani F; Al Ashgar H; Al Kahtani K; Kagevi I; Peedikayil M; Alfadda A; Khan M
Saudi J Gastroenterol; 2015; 21(4):220-5. PubMed ID: 26228365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
